Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 1
1986 2
1987 4
1988 1
1989 1
1990 5
1991 2
1992 1
1993 2
1994 4
1996 3
1997 2
1998 2
1999 1
2000 1
2001 3
2002 2
2003 2
2004 1
2006 1
2007 1
2008 2
2009 2
2011 3
2012 4
2013 3
2014 9
2015 9
2016 6
2017 8
2018 3
2019 9
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

99 results
Results by year
Filters applied: . Clear all
Page 1
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer.
Tagliamento M, Genova C, Rijavec E, Rossi G, Biello F, Dal Bello MG, Alama A, Coco S, Boccardo S, Grossi F. Tagliamento M, et al. Among authors: alama a. Expert Opin Pharmacother. 2018 Dec;19(18):2055-2062. doi: 10.1080/14656566.2018.1540591. Epub 2018 Nov 3. Expert Opin Pharmacother. 2018. PMID: 30392436 Review.
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer.
Rossi G, Alama A, Genova C, Rijavec E, Tagliamento M, Biello F, Coco S, Dal Bello MG, Boccardo S, Grossi F. Rossi G, et al. Among authors: alama a. Expert Opin Pharmacother. 2018 Dec;19(17):1969-1976. doi: 10.1080/14656566.2018.1536746. Epub 2018 Oct 24. Expert Opin Pharmacother. 2018. PMID: 30354693 Review.
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer.
Carbone F, Grossi F, Bonaventura A, Vecchié A, Minetti S, Bardi N, Elia E, Ansaldo AM, Ferrara D, Rijavec E, Dal Bello MG, Biello F, Rossi G, Tagliamento M, Alama A, Coco S, Spallarossa P, Dallegri F, Genova C, Montecucco F. Carbone F, et al. Among authors: alama a. Clin Exp Metastasis. 2019 Oct;36(5):449-456. doi: 10.1007/s10585-019-09984-z. Epub 2019 Aug 2. Clin Exp Metastasis. 2019. PMID: 31376097 Clinical Trial.
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study.
Bonaventura A, Grossi F, Carbone F, Vecchié A, Minetti S, Bardi N, Elia E, Ansaldo AM, Ferrara D, Rijavec E, Dal Bello MG, Rossi G, Biello F, Tagliamento M, Alama A, Coco S, Spallarossa P, Dallegri F, Genova C, Montecucco F. Bonaventura A, et al. Among authors: alama a. Cancer Immunol Immunother. 2019 Aug;68(8):1351-1358. doi: 10.1007/s00262-019-02367-z. Epub 2019 Jul 20. Cancer Immunol Immunother. 2019. PMID: 31327024
Obesity-induced insulin resistance via changes in the DNA methylation profile of insulin pathway genes.
Małodobra-Mazur M, Alama A, Bednarska-Chabowska D, Pawelka D, Myszczyszyn A, Dobosz T. Małodobra-Mazur M, et al. Among authors: alama a. Adv Clin Exp Med. 2019 Dec;28(12):1599-1607. doi: 10.17219/acem/110321. Adv Clin Exp Med. 2019. PMID: 31766080 Free article.
Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab.
Genova C, Boccardo S, Mora M, Rijavec E, Biello F, Rossi G, Tagliamento M, Dal Bello MG, Coco S, Alama A, Vanni I, Barletta G, Bianchi R, Maggioni C, Bruzzi P, Grossi F. Genova C, et al. Among authors: alama a. J Clin Med. 2019 Oct 1;8(10):1566. doi: 10.3390/jcm8101566. J Clin Med. 2019. PMID: 31581482 Free PMC article.
Exosomes: a new horizon in lung cancer.
Vanni I, Alama A, Grossi F, Dal Bello MG, Coco S. Vanni I, et al. Among authors: alama a. Drug Discov Today. 2017 Jun;22(6):927-936. doi: 10.1016/j.drudis.2017.03.004. Epub 2017 Mar 10. Drug Discov Today. 2017. PMID: 28288782 Review.
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, Vanni I, Boccardo S, Rijavec E, Genova C, Biello F, Barletta G, Rossi G, Tagliamento M, Maggioni C, Grossi F. Dal Bello MG, et al. Among authors: alama a. J Transl Med. 2019 Mar 8;17(1):74. doi: 10.1186/s12967-019-1828-0. J Transl Med. 2019. PMID: 30849967 Free PMC article.
Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab.
Alama A, Coco S, Genova C, Rossi G, Fontana V, Tagliamento M, Giovanna Dal Bello M, Rosa A, Boccardo S, Rijavec E, Biello F, Longo L, Cavalieri Z, Bruzzo C, Grossi F. Alama A, et al. J Clin Med. 2019 Jul 10;8(7):1011. doi: 10.3390/jcm8071011. J Clin Med. 2019. PMID: 31295929 Free PMC article.
Pemetrexed for the treatment of non-small cell lung cancer.
Genova C, Rijavec E, Truini A, Coco S, Sini C, Barletta G, Dal Bello MG, Alama A, Savarino G, Pronzato P, Boccardo F, Grossi F. Genova C, et al. Among authors: alama a. Expert Opin Pharmacother. 2013 Aug;14(11):1545-58. doi: 10.1517/14656566.2013.802774. Epub 2013 May 17. Expert Opin Pharmacother. 2013. PMID: 23683110 Review.
99 results
Jump to page
Feedback